BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35190215)

  • 21. Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure.
    Stencel J; Rajapreyar I; Samson R; Le Jemtel T
    Curr Heart Fail Rep; 2022 Oct; 19(5):364-374. PubMed ID: 36045314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diuretics in the Management of Cardiorenal Syndrome.
    Chitturi C; Novak JE
    Adv Chronic Kidney Dis; 2018 Sep; 25(5):425-433. PubMed ID: 30309460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update in diuretic therapy: clinical pharmacology.
    Brater DC
    Semin Nephrol; 2011 Nov; 31(6):483-94. PubMed ID: 22099505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of tolvaptan in heart failure patients with sustained volume overload despite the use of conventional diuretics: a phase III open-label study.
    Fukunami M; Matsuzaki M; Hori M; Izumi T;
    Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S47-56. PubMed ID: 22120093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A perspective on diuretic resistance in chronic congestive heart failure.
    Shah N; Madanieh R; Alkan M; Dogar MU; Kosmas CE; Vittorio TJ
    Ther Adv Cardiovasc Dis; 2017 Oct; 11(10):271-278. PubMed ID: 28728476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
    Yeoh SE; Osmanska J; Petrie MC; Brooksbank KJM; Clark AL; Docherty KF; Foley PWX; Guha K; Halliday CA; Jhund PS; Kalra PR; McKinley G; Lang NN; Lee MMY; McConnachie A; McDermott JJ; Platz E; Sartipy P; Seed A; Stanley B; Weir RAP; Welsh P; McMurray JJV; Campbell RT
    Eur Heart J; 2023 Aug; 44(31):2966-2977. PubMed ID: 37210742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review.
    Felker GM; Ellison DH; Mullens W; Cox ZL; Testani JM
    J Am Coll Cardiol; 2020 Mar; 75(10):1178-1195. PubMed ID: 32164892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds.
    Sarafidis PA; Georgianos PI; Lasaridis AN
    Expert Opin Drug Saf; 2010 Mar; 9(2):243-57. PubMed ID: 20095917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypotension is associated with diuretic resistance in severe chronic heart failure, independent of renal function.
    De Pasquale CG; Dunne JS; Minson RB; Arnolda LF
    Eur J Heart Fail; 2005 Aug; 7(5):888-91. PubMed ID: 15916921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diuretic-resistant heart failure and the role of ultrafiltration: A proposed protocol.
    Gomes da Silva F; Calça R; Rita Martins A; Araújo I; Aguiar C; Fonseca C; Branco P
    Rev Port Cardiol; 2023 Sep; 42(9):797-803. PubMed ID: 36948455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overhydration: A cause or an effect of kidney damage and how to treat it.
    Szymczak A; Kusztal M; Krajewska M
    Adv Clin Exp Med; 2021 Feb; 30(2):219-227. PubMed ID: 33636058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diuretic management in heart failure.
    Michael Felker G
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S68-72. PubMed ID: 20653715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editor's Choice-Diuretic resistance in acute heart failure.
    Verbrugge FH
    Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):379-389. PubMed ID: 29897275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological Properties of Loop Diuretics and Their Clinical Effects].
    Sakalauskienė G; Civinskienė G; Antuševas A; Civinskas P
    Kardiologiia; 2018 Jan; (1):72-83. PubMed ID: 29466174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination diuretic therapy in heart failure].
    Massop K; Kramers CK
    Ned Tijdschr Geneeskd; 2023 May; 167():. PubMed ID: 37257097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
    Mullens W; Dauw J; Martens P; Meekers E; Nijst P; Verbrugge FH; Chenot F; Moubayed S; Dierckx R; Blouard P; Derthoo D; Smolders W; Ector B; Hulselmans M; Lochy S; Raes D; Van Craenenbroeck E; Vandekerckhove H; Hofkens PJ; Goossens K; Pouleur AC; De Ceuninck M; Gabriel L; Timmermans P; Prihadi EA; Van Durme F; Depauw M; Vervloet D; Viaene E; Vachiery JL; Tartaglia K; Ter Maaten JM; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
    Eur J Heart Fail; 2022 Sep; 24(9):1601-1610. PubMed ID: 35733283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loop diuretics in heart failure.
    Felker GM
    Heart Fail Rev; 2012 Mar; 17(2):305-11. PubMed ID: 21516306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diuretic therapy in heart failure].
    Splendiani G; Condò S
    G Ital Nefrol; 2006; 23 Suppl 34():S74-6. PubMed ID: 16634001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction.
    Antonietta CM; Calvi E; Faggiano A; Maffeis C; Bosisio M; De Stefano M; Carugo S; Faggiano P
    Curr Heart Fail Rep; 2022 Feb; 19(1):15-25. PubMed ID: 35037162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loop Diuretics: Clinical Application Information for Nephrology Nurses and Practitioners.
    Nguyen T
    Nephrol Nurs J; 2020; 47(6):553-572. PubMed ID: 33377756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.